Chemoinformaics analysis of Glutaric acid, 3,4-difluorobenzyl nonyl ester
| Molecular Weight | 384.463 | nRot | 14 |
| Heavy Atom Molecular Weight | 354.223 | nRig | 8 |
| Exact Molecular Weight | 384.211 | nRing | 1 |
| Solubility: LogS | -6.269 | nHRing | 0 |
| Solubility: LogP | 5.768 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 59.3958 |
| nHD | 0 | BPOL | 37.5302 |
| QED | 0.315 |
| Synth | 2.09 |
| Natural Product Likeliness | -0.578 |
| NR-PPAR-gamma | 0.343 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.991 |
| Pgp-sub | 0 |
| HIA | 0.001 |
| CACO-2 | -4.75 |
| MDCK | 0.0000229 |
| BBB | 0.276 |
| PPB | 0.970885 |
| VDSS | 0.768 |
| FU | 0.0179445 |
| CYP1A2-inh | 0.891 |
| CYP1A2-sub | 0.177 |
| CYP2c19-inh | 0.79 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.812 |
| CYP2c9-sub | 0.868 |
| CYP2d6-inh | 0.335 |
| CYP2d6-sub | 0.102 |
| CYP3a4-inh | 0.736 |
| CYP3a4-sub | 0.203 |
| CL | 10.205 |
| T12 | 0.308 |
| hERG | 0.258 |
| Ames | 0.01 |
| ROA | 0.112 |
| SkinSen | 0.742 |
| Carcinogencity | 0.142 |
| EI | 0.13 |
| Respiratory | 0.207 |
| NR-Aromatase | 0.191 |
| Antiviral | Yes |
| Prediction | 0.773842 |